Alternatively, the tumour can inhibit DC migration to the tumour-draining lymph node by overexpressing transforming growth factor beta (TGF-β) [156–158], a cytokine found to be produced by many different cancers, and has been associated with poor outcome [159, 160]. Here, TGFB1 is linked to neoplasm.